281 related articles for article (PubMed ID: 10372239)
1. How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin-using patients with type 2 diabetes?
Bouma M; Dekker JH; de Sonnaville JJ; van der Does FE; de Vries H; Kriegsman DM; Kostense PJ; Heine RJ; van Eijk JT
Diabetes Care; 1999 Jun; 22(6):904-7. PubMed ID: 10372239
[TBL] [Abstract][Full Text] [Related]
2. Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria.
Davidson MB; Schriger DL; Peters AL; Lorber B
JAMA; 1999 Apr; 281(13):1203-10. PubMed ID: 10199430
[TBL] [Abstract][Full Text] [Related]
3. Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects.
Ko GT; Chan JC; Yeung VT; Chow CC; Tsang LW; Li JK; So WY; Wai HP; Cockram CS
Diabetes Care; 1998 Aug; 21(8):1221-5. PubMed ID: 9702423
[TBL] [Abstract][Full Text] [Related]
4. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance.
Hu Y; Liu W; Chen Y; Zhang M; Wang L; Zhou H; Wu P; Teng X; Dong Y; Zhou Jw; Xu H; Zheng J; Li S; Tao T; Hu Y; Jia Y
Acta Diabetol; 2010 Sep; 47(3):231-6. PubMed ID: 19760291
[TBL] [Abstract][Full Text] [Related]
5. Influence of Fasting Glucose Levels on Achieving Glycemic Target in Individuals with Type 2 Diabetes: a Post Hoc Analysis.
Ma J; Lei M; Li Y; Zhang X; Cui N; Yang W
Adv Ther; 2020 Sep; 37(9):3816-3826. PubMed ID: 32671687
[TBL] [Abstract][Full Text] [Related]
6. Blood glucose patterns in type 2 diabetic patients with optimal fasting plasma glucose but high HbA1c.
Charoenhirunyingyos W; Nitiyanant W; Thabsang P; Sriussadaporn S; Vannasaeng S
J Med Assoc Thai; 2011 Mar; 94(3):278-85. PubMed ID: 21560834
[TBL] [Abstract][Full Text] [Related]
7. Strategies to detect abnormal glucose metabolism in people at high risk of cardiovascular disease from the ORIGIN (Outcome Reduction with Initial Glargine Intervention) trial population.
Badings EA; Dyal L; Schoterman L; Lok DJ; Stoel I; Gerding MN; Gerstein HC; Tijssen JG
J Diabetes; 2011 Sep; 3(3):232-7. PubMed ID: 21631894
[TBL] [Abstract][Full Text] [Related]
8. Comparative clinical reliability of fasting plasma glucose and glycosylated hemoglobin in non-insulin-dependent diabetes mellitus.
Pecoraro RE; Koepsell TD; Chen MS; Lipsky BA; Belcher DW; Inui TS
Diabetes Care; 1986; 9(4):370-5. PubMed ID: 3743312
[TBL] [Abstract][Full Text] [Related]
9. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
Turner RC; Cull CA; Frighi V; Holman RR
JAMA; 1999 Jun; 281(21):2005-12. PubMed ID: 10359389
[TBL] [Abstract][Full Text] [Related]
10. Influence of Fasting Plasma Glucose Targets on Glycemic Variability in Chinese Participants With Type 2 Diabetes: A Post Hoc Analysis of the FPG GOAL Trial (BEYOND III).
Li L; Yang T; Xue Y; Ruan P; Du J; Li Y; Zhang X; Cui N; Yang W
Adv Ther; 2022 Jan; 39(1):421-429. PubMed ID: 34757600
[TBL] [Abstract][Full Text] [Related]
11. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
[TBL] [Abstract][Full Text] [Related]
12. Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes Importance of postprandial glycemia to achieve target HbA1c levels.
Woerle HJ; Neumann C; Zschau S; Tenner S; Irsigler A; Schirra J; Gerich JE; Göke B
Diabetes Res Clin Pract; 2007 Aug; 77(2):280-5. PubMed ID: 17240473
[TBL] [Abstract][Full Text] [Related]
13. Cause-specific risk of major adverse cardiovascular outcomes and hypoglycemic in patients with type 2 diabetes: a multicenter prospective cohort study.
Sun B; He F; Sun L; Zhou J; Shen J; Xu J; Wu B; Liu R; Wang X; Xu H; Chen X; Zhou H; Liu Z; Zhang W
Endocrine; 2019 Jan; 63(1):44-51. PubMed ID: 30121774
[TBL] [Abstract][Full Text] [Related]
14. Glycated hemoglobin independently or in combination with fasting plasma glucose versus oral glucose tolerance test to detect abnormal glycometabolism in acute ischemic stroke: a Chinese cross-sectional study.
Wu S; Shi Y; Pan Y; Li J; Jia Q; Zhang N; Zhao X; Liu G; Wang Y; Wang Y; Wang C
BMC Neurol; 2014 Sep; 14():177. PubMed ID: 25209629
[TBL] [Abstract][Full Text] [Related]
15. Efficacy, safety, and dose-response characteristics of glipizide gastrointestinal therapeutic system on glycemic control and insulin secretion in NIDDM. Results of two multicenter, randomized, placebo-controlled clinical trials. The Glipizide Gastrointestinal Therapeutic System Study Group.
Simonson DC; Kourides IA; Feinglos M; Shamoon H; Fischette CT
Diabetes Care; 1997 Apr; 20(4):597-606. PubMed ID: 9096986
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics of type 2 diabetes patients with discordance between HbA
Shu H; Lu J; Zhang P; Zhu D; Li X; Ji J; Zhao F; Ji L
Diabetes Metab Res Rev; 2018 May; 34(4):e2977. PubMed ID: 29314667
[TBL] [Abstract][Full Text] [Related]
17. Comparison of fasting plasma glucose and glycated hemoglobin for diagnosing diabetes in a Taiwanese population.
Lai YJ; Lee ST; Kuo SC; Chou P
Metab Syndr Relat Disord; 2015 Jun; 13(5):203-7. PubMed ID: 25734884
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of glycated hemoglobin (HbA1c) for diagnosing type 2 diabetes and prediabetes among Palestinian Arab population.
Kharroubi AT; Darwish HM; Abu Al-Halaweh AI; Khammash UM
PLoS One; 2014; 9(2):e88123. PubMed ID: 24505401
[TBL] [Abstract][Full Text] [Related]
19. Glycated haemoglobin (HbA
Bazo-Alvarez JC; Quispe R; Pillay TD; Bernabé-Ortiz A; Smeeth L; Checkley W; Gilman RH; Málaga G; Miranda JJ
Diabet Med; 2017 Jun; 34(6):804-812. PubMed ID: 28196274
[TBL] [Abstract][Full Text] [Related]
20. Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes.
Horton ES; Clinkingbeard C; Gatlin M; Foley J; Mallows S; Shen S
Diabetes Care; 2000 Nov; 23(11):1660-5. PubMed ID: 11092289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
